Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Business Of Biotech
00:00
The Uniqueness of Moss in Pharma
The platform is now of the is now very robust. We have GMP and we have large volumes available. So we want to position a leva as potential strategic partner for pharma pharma partners that want to develop their product with our technology. Andres: To our knowledge we're the only company worldwide using Moss exploiting Moss commercially for pharmaceutical purposes. The only company is threatening it in any way commercially. But there are products that can can be cannot be made today. And what we do is developing a system for some of those of those we believe that that Moss can solve the problem.
Transcript
Play full episode
